Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 2
1970 1
1992 1
1994 2
1995 3
1996 2
1997 4
1998 1
1999 6
2000 3
2001 3
2002 2
2003 7
2004 7
2005 8
2006 13
2007 8
2008 4
2009 18
2010 14
2011 21
2012 19
2013 12
2014 16
2015 16
2016 21
2017 18
2018 34
2019 23
2020 19
2021 19
2022 9
2023 4
2024 11
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

291 results

Results by year

Filters applied: . Clear all
Page 1
Clinical profile of IgG4-related disease in Japan based on the rare disease data registry.
Yamamoto M, Kanda M, Mizushima I, Kanno A, Umemura T, Ikeura T, Kodama Y, Dobashi H, Tanaka Y, Masamune A, Moriyama M, Saeki T, Matsui S, Origuchi T, Masaki Y, Asada M, Umehara H, Seno H, Naitoh I, Yamamoto S, Iwasaki E, Kubota K, Tanoue S, Nishino T, Tsuboi H, Matsumoto Y, Isayama H, Goto H, Notohara K, Uchida K, Kawabe K, Yamada K, Kasashima S, Takahira M, Sato Y, Kawachi I, Yamaguchi I, Okazaki K, Nakamura S, Matsuda F, Ishikawa H, Kawano M; Patient Registry Committee, Research Program for Intractable Disease by the Ministry of Health, Labour and Welfare (MHLW), Japan. Yamamoto M, et al. Among authors: origuchi t. Immunol Med. 2025 Sep;48(3):192-202. doi: 10.1080/25785826.2024.2430812. Epub 2024 Nov 28. Immunol Med. 2025. PMID: 39607031 Free article.
CD4+ CD52lo T-cell expression contributes to the development of systemic lupus erythematosus.
Umeda M, Koga T, Ichinose K, Igawa T, Sato T, Takatani A, Shimizu T, Fukui S, Nishino A, Horai Y, Hirai Y, Kawashiri SY, Iwamoto N, Aramaki T, Tamai M, Nakamura H, Yamamoto K, Abiru N, Origuchi T, Ueki Y, Kawakami A. Umeda M, et al. Among authors: origuchi t. Clin Immunol. 2018 Feb;187:50-57. doi: 10.1016/j.clim.2017.10.004. Epub 2017 Oct 13. Clin Immunol. 2018. PMID: 29031579
Successful treatment of systemic lupus erythematosus with residual disease activity by switching from belimumab to anifrolumab.
Umeda M, Kojima K, Michitsuji T, Tsuji Y, Shimizu T, Fukui S, Sumiyoshi R, Koga T, Kawashiri SY, Naoki I, Iagawa T, Tamai M, Origuchi T, Furuyama M, Tsuboi M, Matsuoka N, Okada A, Aramaki T, Kawakami A. Umeda M, et al. Among authors: origuchi t. Mod Rheumatol. 2024 Oct 15;34(6):1281-1283. doi: 10.1093/mr/roae038. Mod Rheumatol. 2024. PMID: 38756072 No abstract available.
The 2023 revised diagnostic criteria for IgG4-related dacryoadenitis and sialadenitis.
Kanda M, Nagahata K, Moriyama M, Takano KI, Kamekura R, Yoshifuji H, Tsuboi H, Yamamoto M, Umehara H, Umeda M, Sakamoto M, Maehara T, Inoue Y, Kubo S, Himi T, Origuchi T, Masaki Y, Mimori T, Dobashi H, Tanaka Y, Nakamura S, Takahashi H. Kanda M, et al. Among authors: origuchi t. Mod Rheumatol. 2025 Apr 8;35(3):542-547. doi: 10.1093/mr/roae096. Mod Rheumatol. 2025. PMID: 39441008 Review.
FK506 potentiates steroid-induced T-cell apoptosis.
Migita K, Eguchi K, Kawabe Y, Origuchi T, Tominaga M, Nagataki S. Migita K, et al. Among authors: origuchi t. Transplantation. 1997 Nov 15;64(9):1365-9. doi: 10.1097/00007890-199711150-00022. Transplantation. 1997. PMID: 9371682
A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details.
Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, Matsui S, Sumida T, Mimori T, Tanaka Y, Tsubota K, Yoshino T, Kawa S, Suzuki R, Takegami T, Tomosugi N, Kurose N, Ishigaki Y, Azumi A, Kojima M, Nakamura S, Inoue D; Research Program for Intractable Disease by Ministry of Health, Labor and Welfare (MHLW) Japan G4 team. Umehara H, et al. Mod Rheumatol. 2012 Feb;22(1):1-14. doi: 10.1007/s10165-011-0508-6. Epub 2011 Sep 1. Mod Rheumatol. 2012. PMID: 21881964 Free PMC article. Review.
Evaluating the safety profile of calcineurin inhibitors: cancer risk in patients with systemic lupus erythematosus from the LUNA registry-a historical cohort study.
Ichinose K, Sato S, Igawa T, Okamoto M, Takatani A, Endo Y, Tsuji S, Shimizu T, Sumiyoshi R, Koga T, Kawashiri SY, Iwamoto N, Tamai M, Nakamura H, Origuchi T, Yajima N, Sada KE, Miyawaki Y, Yoshimi R, Shimojima Y, Ohno S, Kajiyama H, Sato S, Fujiwara M, Kawakami A. Ichinose K, et al. Among authors: origuchi t. Arthritis Res Ther. 2024 Feb 12;26(1):48. doi: 10.1186/s13075-024-03285-x. Arthritis Res Ther. 2024. PMID: 38347556 Free PMC article.
Mechanisms underlying immobilization-induced muscle pain in rats.
Oga S, Goto K, Sakamoto J, Honda Y, Sasaki R, Ishikawa K, Kataoka H, Nakano J, Origuchi T, Okita M. Oga S, et al. Among authors: origuchi t. Muscle Nerve. 2020 May;61(5):662-670. doi: 10.1002/mus.26840. Epub 2020 Mar 8. Muscle Nerve. 2020. PMID: 32083755
291 results